MENU

Medical and Scientific Advisors


Medical Advisor
  • John K. Fink, M.D.
    John K. Fink, M.D.

    Dr. Fink is the Director of the Neurogenetic Disorders Clinic at the University of Michigan, Ann Arbor. He’s also a Professor in the university’s Department of Neurology and is a Physician Scientist at the Geriatric Research Education and Clinical Center, Ann Arbor Veterans Affairs Medical Center. His research interests are analysis of inherited and degenerative disorders of the nervous system (including hereditary spastic paraplegia, primary lateral sclerosis, inherited movement disorders, schizophrenia) and regulation of neuronal development.

    Dr. Fink received his M.D. from the Medical College of Ohio in Toledo. He did his residency training in neurology and genetics at the University of Virginia, Charlottesville. At the National Institutes of Health in Bethesda, Maryland, he did a post-doctoral fellowship in the Developmental and Metabolic Neurology and Medical Genetics departments.


Scientific Advisory Board
  • Martha A. Nance MD, Scientific Advisory Board Chairman
    Martha A. Nance MD, Scientific Advisory Board Chairman

    Dr. Nance graduated with a B.S. from Yale University and an M.D. from the Virginia Commonwealth University School Of Medicine in 1984. Dr. Nance works in Saint Louis Park, MN, having over 35 years of diverse experience, especially in neurology and is affiliated with many hospitals including Abbott Northwestern Hospital, Hennepin County Medical Center, Park Nicollet Methodist Hospital, and St Cloud Hospital.

    She specializes in Medical Genetics, Neurology and Psychiatry, is a board certified neurologist and clinical geneticist with special interest in movement disorders such as Parkinson's disease, Huntington’s  disease, Hereditary Ataxias, Hereditary Spastic Paraplegias, and other neurogenetic disorders.  She has served as the medical director of the Struthers Parkinson's Center since 2000. She speaks English, Chinese and Spanish.

    In addition to the care of patients and families with neurologic diseases, she is also involved in clinical research to develop better treatments for Parkin-son's disease and Huntington's disease, and interested in education for both patients and medical professionals. She is a Clinical Professor of Neurology at the University of Minnesota.

    Her other current regional and national professional activities include serving as the Medical Advisor to the Minnesota Chapter of the Huntington's Disease Society of America (1992-), Steering Committee, Enroll-HD study, and Executive Committee, Huntington Study Group (2014-2017)

  • Timothy Angelotti MD, PhD
    Timothy Angelotti MD, PhD

    Associate Professor, Department of Anesthesiology, Perioperative and Pain Medicine, Medical Director, Life Flight (CCT), Stanford University School of Medicine, Stanford, CA.

  • Corey Braastad, PhD
    Corey Braastad, PhD

    Vice President and General Manager of Covance Genomics Laboratories, Springfield, MA.

  • Mary Kay Floeter, MD, PhD
    Mary Kay Floeter, MD, PhD

    Senior Clinician, Motor Neuron Disorders Unit, National Institute for Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD

  • Pedro Gonzalez-Alegre, MD, PhD
    Pedro Gonzalez-Alegre, MD, PhD

    Associate Professor, Department of Neurology; Co-Director, Division of Movement Disorders, Director, Huntington's Disease Center of Excellence, University of Pennsylvania; Perelman Center for Cellular & Molecular Therapeutics, The Children Hospital of Philadelphia, PA.

  • Mark Gudesblatt, MD
    Mark Gudesblatt, MD

    South Shore Neurological Associates, Long Island, NY

  • Peter Hedera, MD, PhD, FACMG
    Peter Hedera, MD, PhD, FACMG

    Associate Professor, Department of Neurology, Division of Movement Disorders, Vanderbilt University, Nashville, TN.

  • Michael Kruer, M.D.
    Michael Kruer, M.D.

    Director, Pediatric Movement Disorders & Neurogenetics Programs, Barrow Neurological Institute, Phoenix Children's Hospital; Associate Professor, Child Health, Neurology & Genetics, University of Arizona College of Medicine; Programs in Neuroscience and Molecular & Cellular Biology, Arizona State University.Phoenix, AZ.

  • Mark S. LeDoux, MD, PhD
    Mark S. LeDoux, MD, PhD

    Professor, Department of Neurology & Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN.

  • Paolo Moretti, MD
    Paolo Moretti, MD

    Chief, Division of Sleep and Movement Disorders, Department of Neurology, University of Utah, Salt Lake City, UT.

  • Niamh O'Sullivan, PhD.
    Niamh O'Sullivan, PhD.

    Assistant Professor, School of Biomolecular and Biomedical Science, University College Dublin, Ireland

  • Shirley Rainier, PhD
    Shirley Rainier, PhD

    Adjunct Research Assistant Professor of Neurology, Medical School, University of Michigan, Ann Arbor, MI.

  • Melissa Rolls Ph.D.
    Melissa Rolls Ph.D.

    Associate Professor of Biochemistry and Molecular Biology; Chair, Molecular, Cellular and Integrative Biosciences program; Director, Center for Cellular Dynamics; Associate Director of the Penn State Hershey MD/PhD program, Penn State, University Park, PA.

  • Jacinda Sampson, M.D., Ph.D.
    Jacinda Sampson, M.D., Ph.D.

    Associate Professor of Neurology, Stanford University, Stanford, CA.